Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sandoz | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Analysis of barriers in psoriasis care from the patient's and the physician's perspective and generation of scientific data on the quality of health care in Denmark, Poland, Spain, and Germany
Cross-sectional, non-interventional study on healthcare for psoriasis in patients and their treating physicians. Clinical data on severity as well as subjective estimates on disease burden, quality of life etc. will be collected. Data collection is planned at multiple, representative sites in fourEuropean countries with different healthcare systems with the aim to identify system-dependent and -independent barriers in guideline-compliant psoriasis care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| psoriasis patients in Denmark | non-interventional survey study in psoriasis patients in daily practice care |
| |
| psoriasis patients in Spain | non-interventional survey study in psoriasis patients in daily practice care |
| |
| psoriasis patients in Poland | non-interventional survey study in psoriasis patients in daily practice care |
| |
| psoriasis patients in Germany | non-interventional survey study in psoriasis patients in daily practice care |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| non-interventional | Other | non-interventional survey study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of patients with severe disease receiving systemic treatment | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Psoriasis Area and Severity Index (PASI) | Psoriasis disease severity, measured by validated instrument | Baseline |
| Body Surface Area (BSA) | Psoriasis-affected body area, measured by physician estimate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
adult patients with diagnosed psoriasis vulgaris
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Matthias Augustin, Prof. Dr. | Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Germany | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Aarhus | 8200 | Denmark | |||
| Nationwide group of dermatological centers, hospitals and medical offices |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011565 | Psoriasis |
| ID | Term |
|---|---|
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline |
| Dermatology Life Quality Index (DLQI) | Quality of life assessment in dermatologic patients, measured by validated quality of life instrument | Baseline |
| EuroQuol (EQ-5D) | generic quality of life assessment, measured by validated visual analogue scale | Baseline |
| Percentage of patients with comorbidities receiving treatment. | Baseline |
| Hamburg |
| Germany |
| Medical University of Poznan | Poznan | 60-355 | Poland |
| Hospital de la Santa Creu i Sant Pau | Barcelona | 08026 | Spain |